- Home
- ACXP vs YCBD Comparison
ACXP vs YCBD Comparison
Compare ACXP & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- YCBD
- Stock Information
- Founded
- ACXP 2017
- YCBD 2015
- Country
- ACXP United States
- YCBD United States
- Employees
- ACXP N/A
- YCBD N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- ACXP Health Care
- YCBD Health Care
- Exchange
- ACXP Nasdaq
- YCBD Nasdaq
- Market Cap
- ACXP 6.8M
- YCBD 7.8M
- IPO Year
- ACXP 2021
- YCBD N/A
- Fundamental
- Price
- ACXP $4.24
- YCBD $1.47
- Analyst Decision
- ACXP Strong Buy
- YCBD Strong Buy
- Analyst Count
- ACXP 3
- YCBD 1
- Target Price
- ACXP $143.67
- YCBD $2.00
- AVG Volume (30 Days)
- ACXP 89.0K
- YCBD 10.9M
- Earning Date
- ACXP 11-12-2025
- YCBD 08-14-2025
- Dividend Yield
- ACXP N/A
- YCBD N/A
- EPS Growth
- ACXP N/A
- YCBD N/A
- EPS
- ACXP N/A
- YCBD N/A
- Revenue
- ACXP N/A
- YCBD $19,026,064.00
- Revenue This Year
- ACXP N/A
- YCBD $0.37
- Revenue Next Year
- ACXP N/A
- YCBD $4.95
- P/E Ratio
- ACXP N/A
- YCBD N/A
- Revenue Growth
- ACXP N/A
- YCBD N/A
- 52 Week Low
- ACXP $3.80
- YCBD $0.59
- 52 Week High
- ACXP $43.20
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- ACXP 51.39
- YCBD 73.03
- Support Level
- ACXP $3.97
- YCBD $0.60
- Resistance Level
- ACXP $4.85
- YCBD $1.94
- Average True Range (ATR)
- ACXP 0.35
- YCBD 0.22
- MACD
- ACXP -0.02
- YCBD 0.07
- Stochastic Oscillator
- ACXP 23.45
- YCBD 63.81
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.